Hepatic fibrosis — new therapeutic approaches

Research output: Contribution to journalEditorial

16 Scopus citations

Abstract

THE management of chronic liver disease, particularly cirrhosis, has focused primarily on treating and preventing the complications of portal hypertension. Unfortunately, there is no therapy that has been proved to prevent progressive hepatic fibrosis or cirrhosis. The use of colchicine, one of the oldest known drugs, has been advocated as a means of preventing and even reversing hepatic fibrosis in patients with alcoholic or nonalcoholic cirrhosis.1 However, many physicians are skeptical, and there have been calls for another randomized, controlled trial, since the drop-out rate and sampling errors inherent in the blind liver-biopsy techniques used in the reported trials could.

Original languageEnglish (US)
Pages (from-to)987-989
Number of pages3
JournalNew England Journal of Medicine
Volume324
Issue number14
DOIs
StatePublished - Apr 4 1991

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Hepatic fibrosis — new therapeutic approaches'. Together they form a unique fingerprint.

  • Cite this